Curcumin as an Adjunct Therapy and microRNA Modulator in Breast Cancer

E-ISSN： 1873-4286|24|2|171-177

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.24, Iss.2, 2018-04, pp. : 171-177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNA-302 Replacement Therapy Sensitizes Breast Cancer Cells to Ionizing Radiation

By Liang Zhongxing Ahn Jeffrey Guo Donna Votaw John Shim Hyunsuk

Pharmaceutical Research, Vol. 30, Iss. 4, 2013-04 ,pp. : 1008-1016

Springer Publishing Company

Access to resources Recommend Favorite

Role of microRNA Deregulation in Breast Cancer Cell Chemoresistance and Stemness

Current Medicinal Chemistry, Vol. 20, Iss. 27, 2013-09 ,pp. : 3358-3369

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy

Current Cancer Drug Targets, Vol. 9, Iss. 4, 2009-06 ,pp. : 572-594

Bentham Science Publishers

Access to resources Recommend Favorite

microRNA, Cancer and Cancer Chemoprevention

Current Molecular Pharmacology, Vol. 5, Iss. 3, 2012-11 ,pp. : 362-371

Bentham Science Publishers

Access to resources Recommend Favorite

Micro-RNA in Disease and Gene Therapy

Current Drug Discovery Technologies, Vol. 8, Iss. 2, 2011-06 ,pp. : 76-86

Bentham Science Publishers

Access to resources Recommend Favorite